Related Experiment Video
Updated: Jan 29, 2026

Characterization of Electrode Materials for Lithium Ion and Sodium Ion Batteries Using Synchrotron Radiation Techniques
Published on: November 11, 2013
Rhombohedral Potassium-Zinc Hexacyanoferrate as a Cathode Material for Nonaqueous Potassium-Ion Batteries
Jongwook W Heo1, Munseok S Chae1, Jooeun Hyoung1
1Department of Energy Science and Engineering , Daegu Gyeongbuk Institute of Science and Technology , Daegu 42988 , Republic of Korea.
Abstract:
Rhombohedral potassium-zinc hexacyanoferrate K1.88Zn2.88[Fe(CN)6]2(H2O)5 (KZnHCF) synthesized using a precipitation method is demonstrated as a high-voltage cathode material for potassium-ion batteries (PIBs), exhibiting an initial discharge capacity of 55.6 mAh g-1 with a discharge voltage of 3.9 V versus K/K+ and a capacity retention of ∼95% after 100 cycles in a nonaqueous electrolyte. All K ions are extracted from the structure upon the initial charge process. However, only 1.61 out of 1.88 K ions per formula unit are inserted back into the structure upon discharge, and it becomes the reversible ion of the second cycle onward. Despite the large ionic size of K, the material exhibits a lattice-volume change (∼3%) during a cycle, which is exceptionally small among the cathode materials for PIBs. The distinct feature of the material seems to come from the unique porous framework structure built by ZnN4 and FeC6 polyhedra linked via the C≡N bond and a Zn/Fe atomic ratio of 3/2, resulting in high structural stability and cycle performance.
Related Concept Videos
Batteries and Fuel Cells
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Roles of Electrolytes: Sodium and Potassium
Oxidation of Alkenes: Syn Dihydroxylation with Potassium Permanganate
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

